Chronic migraine plus medication overuse headache: two entities or not?
about
Neuromodulation of chronic headaches: position statement from the European Headache Federation.Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.Effectiveness of intravenous dexamethasone versus propofol for pain relief in the migraine headache: a prospective double blind randomized clinical trial.Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation.CGRP receptor antagonists: an expanding drug class for acute migraine?Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache.Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety.Questioning on consistency of a stagnation scale in medication overuse headache: one more added to a plea of emperor's clothes?Chronic migraine classification: current knowledge and future perspectivesPsychometric properties of the stagnation scale in medication overuse headache patients.Analysis of risk factors for medication-overuse headache relapse: a clinic-based study in China.Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headacheDoes analgesic overuse matter? Response to OnabotulinumtoxinA in patients with chronic migraine with or without medication overuseMigraine incidence in 5 years: a population-based prospective longitudinal study in Turkey.OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study.A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience.Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial.Increased efficacy of regularly repeated cycles with OnabotulinumtoxinA in MOH patients beyond the first year of treatment.Field testing of the ICHD-3β and expert opinion criteria for chronic migraine.Treatment of perimenstrual migraine with triptans: an update.Onabotulinum toxin A for the treatment of neurogenic detrusor overactivity due to spinal cord injury or multiple sclerosis.Emerging treatment for chronic migraine and refractory chronic migraine.Treatment of menstrual migraine: utility of control of related mood disturbances.Medication overuse headache - An under-diagnosed problem in shunted idiopathic intracranial hypertension patients.Chronic migraine treatment: from OnabotulinumtoxinA onwards.Nucleus accumbens functional connectivity discriminates medication-overuse headache.Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache.Chronic migraine classification: one more attempt of optimization and criteria revision.Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy.Update on Medication-Overuse Headache and Its Treatment.Acute treatment of migraine: quo vadis?The journey from genetic predisposition to medication overuse headache to its acquisition as sequela of chronic migraine.Pharmacokinetic evaluation of almotriptan for the treatment of migraines.Serotonin receptor agonists in the acute treatment of migraine: a review on their therapeutic potential.[Relaxation techniques and behavioural therapy for the treatment of migraine : Guidelines from the German Migraine and Headache Society].A Critical Evaluation on MOH Current Treatments.OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication OveruseValidation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire
P2860
Q21146948-C8714A77-E993-4E6F-A627-0AE431198713Q30846961-AC8D2B9A-0A0C-487C-BAA5-18F7ED689B08Q34423785-3A1A9227-535A-4B75-B2A9-32BB517C20FEQ34544375-B6BA5A8C-ABB7-4415-8B12-EAC106740A09Q34637610-4F1F5AEE-C778-48E4-956B-17DB05B80663Q34658957-2F6FC108-FEA7-4676-848F-8AA2BC3354CBQ35121186-1383B7CA-4500-4BD7-A846-C88496BDCC8BQ35264506-93C50FDD-4989-445A-8456-F680C68F45C1Q35522685-810D971A-9555-4683-832F-A1CA18ECBDA4Q35599467-8BAAAA23-A66A-4DB1-98A8-F2F010BEC1F2Q35779990-CD8021F0-BD5F-4A50-BD5C-B61687CD8587Q35952546-EEA6FFFC-465E-49D7-A622-5BE825A9C8C3Q36234332-1C487AE8-CC55-433F-AFE2-DAD2A9AAF963Q36345844-E1A52912-C792-4D9B-B40A-14505AE66770Q36415380-417F817B-29BB-459D-9651-446F5F7D4825Q36484239-410C153E-8B05-44DA-943A-3DA749D19F75Q36749549-02221282-C9B4-4F93-ACB2-3A3E8D00F84DQ36869674-307C57A8-CA77-4CD3-8C27-DBA82F79C1C1Q37266109-85A4F65A-94EC-4F23-B45F-578231CA7FF9Q38014363-EBAF5E90-5706-4B32-A607-71B0A8B1AD09Q38031284-78038A29-3031-4987-9D25-3F5DE069FD3AQ38031982-18C00311-2ABB-40B0-9282-C5FA22A53319Q38202138-9BC8516C-ED1B-4638-94F1-2733A04FD3D4Q38241239-A950B7D0-18E6-4394-BEFC-92E7BF5496D3Q38866988-6AFD4ACD-261E-44F2-9A44-A8C86A5E0BE3Q39664653-FA1A09FA-3E15-4CEE-A69C-F074D5567A5EQ40743726-E00DD41A-480F-4A4E-86D9-6D65C1164764Q41819355-AA39CFDE-2B31-4D79-A767-C8651467ECF5Q47133621-21B1F469-698A-4A93-BEB0-A5EDCCAF73E5Q47635235-AFB9603C-507E-4B3D-9ECC-8E6FEF8056B7Q48131347-CB6DCED5-AD78-4EAC-A978-A70C798C0E92Q49792274-B680BDA8-C4BF-4341-AC5B-D427F1D9542FQ50490563-7889C540-1683-4D41-BA5F-E8182AD9098FQ52643768-2AA63C97-5ED9-4127-AC82-53F746228217Q53635786-C61B9DAC-9CAE-43B7-92A1-4D43B68CF5ECQ54795534-564666DE-CA27-4AE0-8717-014A192609C0Q58554016-AEA45F1A-85BE-4BFB-8FAA-80F01B3FD0B0Q58755897-281FC16A-AB9A-49FE-8726-C4E5301432AD
P2860
Chronic migraine plus medication overuse headache: two entities or not?
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chronic migraine plus medication overuse headache: two entities or not?
@ast
Chronic migraine plus medication overuse headache: two entities or not?
@en
type
label
Chronic migraine plus medication overuse headache: two entities or not?
@ast
Chronic migraine plus medication overuse headache: two entities or not?
@en
prefLabel
Chronic migraine plus medication overuse headache: two entities or not?
@ast
Chronic migraine plus medication overuse headache: two entities or not?
@en
P2860
P921
P1476
Chronic migraine plus medication overuse headache: two entities or not?
@en
P2093
Andrea Negro
P2860
P2888
P304
P356
10.1007/S10194-011-0388-3
P577
2011-09-22T00:00:00Z
2011-12-01T00:00:00Z